We can't find the internet
Attempting to reconnect
12803.1;11 VOUCH-LS
Innovative 'armed' antibodies
Zusammenfassung
Innovative 'armed' antibodies
Weitere Texte
Abstract
Monoclonal antibodies represent the largest and fastest growing class of biotechnology products. While conventional antibody products are based on intact IgG, there is a growing trend towards ¿arming¿ antibodies with therapeutic payloads. The Philogen group is one of the pioneers in the engineering of armed human antibodies for therapeutic applications. In order to retain and consolidate its leadership in the field, we need to stay ahead of competition and explore innovative immunocytokines, alongside with their possible clinical application areas.
Beteiligte
Dario Neri
Kontaktperson
dario.neri@pharma.ethz.ch
ETH Zürich Inst. of Pharmac. Sciences Dario Neri Wolfgang-Paulistrasse 10 HCI G496 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2012-03-31
- Enddatum
- 2015-11-11
- Bewilligte Gesamtkosten
- CHF 347744.00
- Sektion
- 5 KTI
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%